According to KP Biotech, on September 14, KP Biotech and Golden Key Technology officially signed an agreement to deepen strategic cooperation. Based on the foundation of collaboration over the past three years, the two sides have once again upgraded cooperation in the field of accurate diagnosis of infectious diseases, and jointly promoted the implementation of advanced high-throughput detection technologies such as pathogen metagenomic sequencing and targeted pathogen sequencing, from central laboratories to medical institutions at all levels to help raise the level of diagnosis and treatment of difficult and critical infectious diseases in China.

According to KP Biotech, on September 14, KP Biotech and Golden Key Technology officially signed an agreement to deepen strategic cooperation. Based on the foundation of collaboration over the past three years, the two sides have once again upgraded cooperation in the field of accurate diagnosis of infectious diseases, and jointly promoted the implementation of advanced high-throughput detection technologies such as pathogen metagenomic sequencing and targeted pathogen sequencing, from central laboratories to medical institutions at all levels to help raise the level of diagnosis and treatment of difficult and critical infectious diseases in China.